chronic eye disease
Allergan’s chronic eye disease treatment meets endpoints in pivotal trials
May 17, 2016Manufacturing and Production, Sales and Marketing Allergan, FDA, chronic eye disease
Allergan has announced positive top line results from two pivotal late-stage trials for the first and only neurostimulation device for …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
